- Home
- STKH vs TCRT Comparison
STKH vs TCRT Comparison
Compare STKH & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKH
- TCRT
- Stock Information
- Founded
- STKH 2018
- TCRT 1998
- Country
- STKH Israel
- TCRT United States
- Employees
- STKH N/A
- TCRT N/A
- Industry
- STKH Packaged Foods
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- STKH Consumer Staples
- TCRT Health Care
- Exchange
- STKH Nasdaq
- TCRT Nasdaq
- Market Cap
- STKH 4.6M
- TCRT 3.8M
- IPO Year
- STKH 2021
- TCRT N/A
- Fundamental
- Price
- STKH $1.52
- TCRT $1.90
- Analyst Decision
- STKH
- TCRT
- Analyst Count
- STKH 0
- TCRT 0
- Target Price
- STKH N/A
- TCRT N/A
- AVG Volume (30 Days)
- STKH 35.3K
- TCRT 33.0K
- Earning Date
- STKH 08-30-2024
- TCRT 11-14-2024
- Dividend Yield
- STKH N/A
- TCRT N/A
- EPS Growth
- STKH N/A
- TCRT N/A
- EPS
- STKH N/A
- TCRT N/A
- Revenue
- STKH N/A
- TCRT $7,000.00
- Revenue This Year
- STKH N/A
- TCRT N/A
- Revenue Next Year
- STKH N/A
- TCRT N/A
- P/E Ratio
- STKH N/A
- TCRT N/A
- Revenue Growth
- STKH N/A
- TCRT N/A
- 52 Week Low
- STKH $1.47
- TCRT $1.63
- 52 Week High
- STKH $7.70
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- STKH 22.37
- TCRT 43.99
- Support Level
- STKH $1.45
- TCRT $1.63
- Resistance Level
- STKH $1.82
- TCRT $2.10
- Average True Range (ATR)
- STKH 0.22
- TCRT 0.30
- MACD
- STKH -0.04
- TCRT -0.04
- Stochastic Oscillator
- STKH 6.00
- TCRT 21.03
About STKH Steakholder Foods Ltd.
Steakholder Foods Ltd is a deep-tech food company. The company is cultivating meat technologies to improve meat production, simplify the meat supply chain, and offer consumers a range of new product offerings. The company aims to provide an alternative to industrialized animal farming that reduces carbon footprint, minimizes water and land usage, and prevents the slaughtering of animals. It is developing a novel, proprietary three-dimensional bioprinter for three-dimensional printing of meat and seafood analogs, followed by hybrid meats that combine cultivated and plant-based elements.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.